Rosemount Drug Patent Portfolio
Rosemount owns 4 orange book drugs protected by 9 US patents Given below is the list of Rosemount's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11103452 | Tramadol hydrochloride solution | 01 Sep, 2040 | Active |
| US11752103 | Tramadol hydrochloride solution | 01 Sep, 2040 | Active |
| US10610502 | Oral baclofen solutions | 30 Aug, 2039 | Active |
| US8623409 | Clonidine formulation | 08 Sep, 2031 | Active |
| US7569612 | Methods of use of fenofibric acid | 20 Aug, 2027 | Active |
| US7741373 | Methods of use of fenofibric acid | 20 Aug, 2027 | Active |
| US7741374 | Methods of use of fenofibric acid | 20 Aug, 2027 | Active |
| US7915247 | Methods of use of fenofibric acid | 20 Aug, 2027 | Active |
| US8337890 | Modified release formulations containing drug-ion exchange resin complexes | 17 Apr, 2027 | Active |
Latest Legal Activities on Rosemount's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Rosemount.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Email Notification | 31 Oct, 2025 | US10610502 |
| Change in Power of Attorney (May Include Associate POA) | 31 Oct, 2025 | US10610502 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 30 Jun, 2025 | US8623409 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 09 Jan, 2025 | US11103452 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 May, 2024 | US8337890 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 08 Nov, 2023 | US10610502 |
| Surcharge for late Payment, Small Entity | 08 Nov, 2023 | US10610502 |
| Recordation of Patent eGrant | 12 Sep, 2023 | US11752103 |
| Patent eGrant Notification | 12 Sep, 2023 | US11752103 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Sep, 2023 | US11752103 |
|
Recordation of Patent Grant Mailed
Critical
| 12 Sep, 2023 | US11752103 |
|
Email Notification
Critical
| 12 Sep, 2023 | US11752103 |
| Mail Patent eGrant Notification | 12 Sep, 2023 | US11752103 |
|
Email Notification
Critical
| 24 Aug, 2023 | US11752103 |
|
Issue Notification Mailed
Critical
| 23 Aug, 2023 | US11752103 |
Rosemount's Family Patents
Rosemount Drug List
Given below is the complete list of Rosemount's drugs and the patents protecting them.
1. Fibricor
Fibricor is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7569612 | Methods of use of fenofibric acid |
20 Aug, 2027
(11 months from now)
| Active |
| US7741373 | Methods of use of fenofibric acid |
20 Aug, 2027
(11 months from now)
| Active |
| US7741374 | Methods of use of fenofibric acid |
20 Aug, 2027
(11 months from now)
| Active |
| US7915247 | Methods of use of fenofibric acid |
20 Aug, 2027
(11 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fibricor's drug page
2. Nexiclon Xr
Nexiclon Xr is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8623409 | Clonidine formulation |
08 Sep, 2031
(4 years from now)
| Active |
| US8337890 | Modified release formulations containing drug-ion exchange resin complexes |
17 Apr, 2027
(7 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nexiclon Xr's drug page
3. Ozobax
Ozobax is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10610502 | Oral baclofen solutions |
30 Aug, 2039
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ozobax's drug page
4. Qdolo
Qdolo is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11103452 | Tramadol hydrochloride solution |
01 Sep, 2040
(13 years from now)
| Active |
| US11752103 | Tramadol hydrochloride solution |
01 Sep, 2040
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qdolo's drug page